Skip to main content

CASE REPORT article

Front. Nephrol.
Sec. Onconephrology
Volume 4 - 2024 | doi: 10.3389/fneph.2024.1399977

Triple monoclonal protein-related kidney lesions in a patient with plasma cell dyscrasia: A case report

Provisionally accepted
Arsalan Alvi Arsalan Alvi 1Alexander J. Gallan Alexander J. Gallan 2Nattawat Klomjit Nattawat Klomjit 1*
  • 1 Division of Nephrology and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, United States
  • 2 Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States

The final, formatted version of the article will be published soon.

    A toxic monoclonal protein typically results in a single kidney pathology due to specific biophysical characteristics of monoclonal proteins. Multiple monoclonal protein lesions are rarely reported and often portend poor prognosis. We present a 57-year-old male who developed rapidly progressive glomerulonephritis after concealed ruptured diverticulitis. A kidney biopsy showed light chain cast nephropathy, light chain proximal tubulopathy, and thrombotic microangiopathy. Laboratories showed IgG kappa with an M-spike of 0.2 g/dl and a kappa light chain of 16 mg/dl. A bone marrow biopsy showed 3% kappa-restricted plasma cells. The dramatic renal presentation despite the minimal hematological burden is suggestive of a highly toxic light chain, which is consistent with monoclonal gammopathy of renal significance (MGRS). Clone-directed therapy and a complement blockade were initiated. The patient remained dialysis-dependent despite a hematological response. This case highlights the importance of toxic properties of monoclonal protein in causing kidney diseases. Our case is the first report of an MGRS patient with three distinct kidney lesions. Triple monoclonal protein related kidney lesions are very rare and are usually associated with multiple myeloma. LCCN is a myeloma defining event but his LC (<50 mg/dl) and plasma cell burden was low (<10%) which makes this case very unusual. Sepsis-induced low flow stage and toxic properties of LC may induce LCCN in this patient. Aggressive therapy is likely needed to eradicate the clone in order to achieve an organ response.

    Keywords: monoclonal gammopathy of renal significance, MGRS, Multiple Myeloma, thrombotic microangiopathy, TMA, light chain proximal tubulopathy, LCPT, Light chain cast nephropathy

    Received: 12 Mar 2024; Accepted: 08 Oct 2024.

    Copyright: © 2024 Alvi, Gallan and Klomjit. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Nattawat Klomjit, Division of Nephrology and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, 55414, Minnesota, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.